Synthetic Biologics Inc (SYN)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Steven A. Shallcross
Employees:
20
617 DETROIT STREET, SUITE 100, ANN ARBOR, MI 48104
(734) 332-7800

Synthetic Biologics, Inc. develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade intravenous beta-lactam antibiotics in gastrointestinal (GI) tract. It also develops VCN-01 for the treatment of patients with pancreatic cancer, head and neck squamous cell carcinoma, colorectal cancer, and retinoblastoma.

Data derived from most recent annual or quarterly report
Market Cap 164.775 Million Shares Outstanding158.438 Million Avg 30-day Volume 77.948 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.02
Price to Revenue0.0 Debt to Equity0.0354 EBITDA-9.959 Million
Price to Book Value0.0 Operating Margin0.0 Enterprise Value13.742 Million
Current Ratio2.675 EPS Growth0.327 Quick Ratio2.1
1 Yr BETA 0.9932 52-week High/Low 4.9 / 1.03 Profit Margin0.0
Operating Cash Flow Growth12.2901 Altman Z-Score-43.1916 Free Cash Flow to Firm -9.781 Million

Are you looking for this stock instead?

View SEC Filings from SYN instead.

View recent insider trading info

Funds Holding SYN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SYN

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-09-27:
    Item 7.01: Regulation FD Disclosure
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-09-12:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K/A: filed on 2022-09-06:
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-09-06:
    Item 7.01: Regulation FD Disclosure
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-11:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-03:
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-29:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 3.02: Unregistered Sales of Equity Securities
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-25:
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-15:
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-14:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    TUFARO FRANCIS CHIEF OPERATING OFFICER

    • Officer
    806,452 2022-03-22 1

    MONAHAN JOHN J

    • Director
    200,000 2021-12-23 1

    SHALLCROSS STEVEN A CEO AND CFO

    • Officer
    • Director
    650,000 2021-12-23 1

    KRAWS JEFFREY J

    • Director
    200,000 2021-12-23 1

    WOLF JEFFREY ALAN

    • Director
    200,000 2021-12-23 1

    TARRIFF SCOTT

    • FORMER DIRECTOR
    No longer subject to file 2020-11-11 0

    KIRK RANDAL J

    INTREXON CORP

    • 10% Owner
    No longer subject to file 2019-04-01 0

    SLIMAN JOSEPH A. CHIEF MEDICAL OFFICER

    • Officer
    0 2017-12-20 0

    RILEY JEFFREY SCOTT CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    0 2016-11-30 0

    BALLANTYNE CHARLES EVAN CHIEF FINANCIAL OFFICER

    • Officer
    0 2015-01-08 0

    KANZER STEVE H

    • 10% Owner
    • PRIOR DIRECTOR
    No longer subject to file 2014-04-30 0

    STACKS NELSON K.

    • Director
    0 2012-02-03 0

    KUO JAMES S CHAIRMAN, CEO & PRESIDENT

    • Officer
    • Director
    4,500 2011-08-30 0

    LYON LYMAN MAX JR CEO & PRESIDENT

    • Officer
    • Director
    0 2009-12-08 0

    STERGIS NICHOLAS CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    0 2008-07-08 0

    DORMAN DANIEL J

    • Director
    761,192 2007-11-09 0

    RIDGEBACK CAPITAL INVESTMENTS LTD.

    RIDGEBACK CAPITAL MANAGEMENT LLC

    HOLMAN WAYNE GEORGE

    • 10% Owner
    1,856,565 2007-11-09 0

    BISGAIER CHARLES PHD PRESIDENT

    • Officer
    • Director
    1,586,264 2007-07-16 0

    RUDICK A JOSEPH

    • Director
    0 2006-10-31 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    SYNTHETIC BIOLOGICS INC SYN 2022-09-27 22:15:03 UTC -4.7773 7.8473 55000
    SYNTHETIC BIOLOGICS INC SYN 2022-09-27 21:45:03 UTC -4.7344 7.8044 55000
    SYNTHETIC BIOLOGICS INC SYN 2022-09-27 21:15:03 UTC -4.7344 7.8044 55000
    SYNTHETIC BIOLOGICS INC SYN 2022-09-27 20:45:03 UTC -4.7344 7.8044 55000
    SYNTHETIC BIOLOGICS INC SYN 2022-09-27 20:15:05 UTC -4.7344 7.8044 55000
    SYNTHETIC BIOLOGICS INC SYN 2022-09-27 19:45:03 UTC -4.7344 7.8044 55000
    SYNTHETIC BIOLOGICS INC SYN 2022-09-27 19:15:03 UTC -4.7344 7.8044 55000
    SYNTHETIC BIOLOGICS INC SYN 2022-09-27 18:45:03 UTC -4.7344 7.8044 55000
    SYNTHETIC BIOLOGICS INC SYN 2022-09-27 18:15:03 UTC -4.7344 7.8044 55000
    SYNTHETIC BIOLOGICS INC SYN 2022-09-27 17:45:03 UTC -4.7344 7.8044 55000
    SYNTHETIC BIOLOGICS INC SYN 2022-09-27 17:15:03 UTC -4.7344 7.8044 55000
    SYNTHETIC BIOLOGICS INC SYN 2022-09-27 16:45:03 UTC -4.6701 7.7401 55000
    SYNTHETIC BIOLOGICS INC SYN 2022-09-27 16:15:03 UTC -4.6701 7.7401 55000
    SYNTHETIC BIOLOGICS INC SYN 2022-09-27 15:45:04 UTC -4.6701 7.7401 55000
    SYNTHETIC BIOLOGICS INC SYN 2022-09-27 15:15:03 UTC -4.6701 7.7401 55000
    SYNTHETIC BIOLOGICS INC SYN 2022-09-27 14:45:04 UTC -4.6701 7.7401 55000
    SYNTHETIC BIOLOGICS INC SYN 2022-09-27 14:15:03 UTC -4.6701 7.7401 55000
    SYNTHETIC BIOLOGICS INC SYN 2022-09-27 13:45:03 UTC -4.0442 7.1142 55000
    SYNTHETIC BIOLOGICS INC SYN 2022-09-27 13:15:04 UTC -4.0442 7.1142 55000
    SYNTHETIC BIOLOGICS INC SYN 2022-09-27 12:45:03 UTC -4.0442 7.1142 55000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    Elevate your investments